Tripeptide interference with human immunodeficiency virus type 1 morphogenesis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 11, 2002, Pages 3597-3605

  Höglund, Stefan ^a   Su, Jin ^a   Reneby, Sara Sandin ^a   Végvári, Ákos ^a   Hjertén, Stellan ^a   Sintorn, Ida Maria ^a   Foster, Hillary ^a   Wu, Yi Pyng ^a   Nyström, Ingela ^a   Vahlne, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLLEUCYLGLYCINAMIDE; ANTIVIRUS AGENT; ARGINYLGLUTAMINYLGLYCINAMIDE; CAPSID PROTEIN; GAG PROTEIN; GLYCYLPROLYLGLYCINAMIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING KINETICS; CAPILLARY ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; DRUG POTENCY; DRUG TARGETING; ELECTRON MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROGENY; VIRUS CAPSID; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

CAPSID PROTEINS; CELLS, CULTURED; ELECTROPHORESIS, CAPILLARY; HIV CORE PROTEIN P24; HIV-1; HUMANS; MICROSCOPY, ELECTRON; MORPHOGENESIS; OLIGOPEPTIDES; VIRUS REPLICATION;

EID: 0036841348     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.11.3597-3605.2002     Document Type: Article

References (48)

1. Amini, A., U. Paulsen-Sorman, and D. Westerlund. 1999. Principle and application of the partial filling technique in capillary electrophoresis. Chromatographia 50:497-506.
2. Badger, J., I. Minor, M. J. Kremer, M. A. Oliveira, T. J. Smith, J. P. Griffith, D. M. Guerin, S. Krishnaswamy, M. Luo, M. G. Rossmann, et al. 1988. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc. Natl. Acad. Sci. USA 85:3304-3308.
3. Borsetti, A., A. Ohagen, and H. G. Gottlinger. 1998. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 72:9313-9317.
4. Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
5. Challand, R., and R. Young. 1997. Antiviral chemotherapy. Spektrum Academic Publishers, Oxford, United Kingdom.
6. Chazal, N., C. Carriere, B. Gay, and P. Boulanger. 1994. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J. Virol. 68:111-122.
7. Chu, Y. H., and C. C. Cheng. 1998. Affinity capillary electrophoresis in biomolecular recognition. Cell. Mol. Life Sci. 54:663-683.
8. Dorfman, T., A. Bukovsky, A. Ohagen, S. Höglund, and H. G. Gottlinger. 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:8180-8187.
9. Ehrlich, L. S., B. E. Agresta, and C. A. Carter. 1992. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:4874-4883.
10. Endrich, M. M., P. Gehrig, and H. Gehring. 1999. Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain. J. Biol. Chem. 274:5326-5332.
11. 2-terminal capsid domain: structure determination for proper core assembly and subsequent steps of early replication. Virology 268:294-307.
12. Folks, T., D. M. Powell, M. M. Lightfoote, S. Benn, M. A. Martin, and A. S. Fauci. 1986. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implication for latency. Science 231:600-602.
13. Franke, E. K., H. E. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
14. Gamble, T. R., F. F. Vajdos, S. Yoo, D. K. Worthylake, M. Houseweart, W. I. Sundquist, and C. P. Hill. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87:1285-1294.
15. Gamble, T. R., S. Yoo, F. F. Vajdos, U. K. von Schwedler, D. K. Worthylake, H. Wang, J. P. McCutcheon, W. I. Sundquist, and C. P. Hill. 1997. Structure of the carboxy-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853.
16. Ganser, B. K., S. Li, V. Y. Klishko, J. T. Finch, and W. I. Sundquist. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83.
17. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
18. Grant, R. A., C. N. Hiremath, D. J. Filman, R. Syed, K. Andries, and J. M. Hogle. 1994. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr. Biol. 4:784-797.
19. Gross, I., H. Hohenberg, C. Huckhagel, and H. G. Krausslich. 1998. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:4798-4810.
20. Gross, I., H. Hohenberg, T. Wilk, K. Wiegers, M. Grattinger, B. Muller, S. Fuller, and H. G. Krausslich. 2000. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19:103-113.
21. Harrison, S., D. C. Wiley, and J. J. Skehel. 1996. Virus structure, p. 59-100. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
22. Hjertén, S. 1977. Analysis and purification of cells with the free zone electrophoresis equipment, p. 117-128. In B. Loemendal (ed.), Cell separation methods. Elsevier/North-Holland Biomedical Press, Amsterdam, The Netherlands.
23. Hjertén, S. 1985. High-performance electrophoresis. Elimination of electroendosmosis and solute adsorption. J. Chromatogr. 347:191-198.
24. Höglund, S., L. G. Ofverstedt, A. Nilsson, P. Lundquist, H. Gelderblom, M. Ozel, and U. Skoglund. 1992. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res. Hum. Retrovir. 8:1-7.
25. Horal, P., W. W. Hall, B. Svennerholm, J. Lycke, S. Jeansson, L. Rymo, M. H. Kaplan, and A. Vahlne. 1991. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc. Natl. Acad. Sci. USA 88:5754-5758.
26. Kaufman, A. 1990. Volume visualization. IEEE Computer Society Press, Los Alamitos, Calif.
27. Li, S., C. P. Hill, W. I. Sundquist, and J. T. Finch. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413.
28. Luciw, P. A. 1996. Human immunodeficiency viruses and their replication, p. 1881-1952. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
29. Molteni, S., H. Frischknecht, and W. Thormann. 1994. Application of dynamic capillary isoelectric focusing to the analysis of human hemoglobin variants. Electrophoresis 15:22-30.
30. Montagnier, L., and F. Clavel. 1994. Human immunodeficiency viruses, p. 671-681. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology, vol. 2. Academic Press, London, England.
31. Niedrig, M., H. R. Gelderblom, G. Pauli, J. Marz, H. Bickhard, H. Wolf, and S. Modrow. 1994. Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein-derived peptides. J. Gen. Virol. 75:1469-1474.
32. Phelps, D. K., and C. B. Post. 1995. A novel basis of capsid stabilization by antiviral compounds. J. Mol. Biol. 254:544-551.
33. Reicin, A. S., S. Paik, R. D. Berkowitz, J. Luban, I. Lowy, and S. P. Goff. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:642-650.
34. Rossmann, M. G. 1989. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids. Antiviral Res. 11:3-13.
35. Su, J., E. Andersson, P. Horal, M. H. Naghavi, A. Palm, Y. Wu, K. Eriksson, M. Jansson, H. Wigzell, B. Svennerholm, and A. Vahlne. 2001. The non-toxic tripeptide glycyl-prolyl-glicine amide inhibits the replication of HIV-1. J. Hum. Virol. 4:1-7.
36. 2 does not affect the early steps of the HIV-1 replication. J. Hum. Virol. 4:8-15.
37. Sundqvist, V. A., J. Albert, E. Ohlsson, J. Hinkula, E. M. Fenyo, and B. Wahren. 1989. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J. Med. Virol. 29:170-175.
38. Vahlne, A., P. Horal, K. Eriksson, S. Jeansson, L. Rymo, K. G. Hedstrom, C. Czerkinsky, J. Holmgren, and B. Svennerholm. 1991. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition. Proc. Natl. Acad. Sci. USA 88:10744-10748.
39. Vajdos, F. F., S. Yoo, M. Houseweart, W. I. Sundquist, and C. P. Hill. 1997. Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci. 6:2297-2307.
40. Valtcheva, L., J. Mohammad, G. Petterson, and S. Hjertén. 1993. Chiral separation of β-blockers by high-performance capillary electrophoresis based on non-immobilized cellulase as enantioselective protein. J. Chromatogr. 638:263-267.
41. von Poblotzki, A., R. Wagner, M. Niedrig, G. Wanner, H. Wolf, and S. Modrow. 1993. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. Virology 193:981-985.
42. von Schwedler, U. K., T. L. Stemmler, V. Y. Klishko, S. Li, K. H. Albertine, D. R. Davis, and W. I. Sundquist. 1998. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1555-1568.
43. Wang, C. T., and E. Barklis. 1993. Assembly, processing, and infectivity of the immunodeficiency virus type 1 gag mutants. J. Virol. 67:4264-4273.
44. Wang, C. T., H. Y. Lai, and J. J. Li. 1998. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J. Virol. 72:7950-7959.
45. Welker, R., H. Hohenberg, U. Tessmer, C. Huckhagel, and H. G. Krausslich. 2000. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J. Virol. 74:1168-1177.
46. Wiegers, K., G. Rutter, H. Kottler, U. Tessmer, H. Hohenberg, and H. G. Krausslich. 1998. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:2846-2854.
47. Yoo, S., D. G. Myszka, C. Yeh, M. McMurray, C. P. Hill, and W. I. Sundquist. 1997. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 269:780-795.
48. Zhao, Y., Y. Chen, M. Schutkowski, G. Fischer, and H. Ke. 1997. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 5:139-146.